-
Article
Open AccessGenome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D
Affecting about 1 in 12 Americans annually, depression is a leading cause of the global disease burden. While a range of effective antidepressants are now available, failure and relapse rates remain substantia...
-
Article
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
Understanding individual differences in the susceptibility to metabolic side effects as a response to antipsychotic therapy is essential to optimize the treatment of schizophrenia. Here, we perform genomewide ...
-
Article
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
Schizophrenia is an often devastating neuropsychiatric illness. Understanding the genetic variation affecting response to antipsychotics is important to develop novel diagnostic tests to match individual schiz...